These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
748 related items for PubMed ID: 17296879
21. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, Lip GY, Crijns HJ, Euro Heart Survey Investigators. Eur Heart J; 2008 Apr; 29(7):915-22. PubMed ID: 18334476 [Abstract] [Full Text] [Related]
22. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. Mant JW, Richards SH, Hobbs FD, Fitzmaurice D, Lip GY, Murray E, Banting M, Fletcher K, Rahman J, Allan T, Raftery J, Bryan S, Midlands Research Consortium of General Practice. BMC Cardiovasc Disord; 2003 Aug 26; 3():9. PubMed ID: 12939169 [Abstract] [Full Text] [Related]
25. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Thromb Haemost; 2009 Feb 26; 101(2):367-72. PubMed ID: 19190823 [Abstract] [Full Text] [Related]
26. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs. Garcia DA, Lopes RD, Hylek EM. Thromb Haemost; 2010 Dec 26; 104(6):1099-105. PubMed ID: 20886196 [Abstract] [Full Text] [Related]
27. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. Waldo AL, Becker RC, Tapson VF, Colgan KJ, NABOR Steering Committee. J Am Coll Cardiol; 2005 Nov 01; 46(9):1729-36. PubMed ID: 16256877 [Abstract] [Full Text] [Related]
28. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1. Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B. Thromb Haemost; 2010 Apr 01; 103(4):833-40. PubMed ID: 20135077 [Abstract] [Full Text] [Related]
32. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM. Am J Med; 2006 Jul 01; 119(7):607-15. PubMed ID: 16828633 [Abstract] [Full Text] [Related]
33. Anticoagulation in atrial fibrillation. Anderson M, Kirk M. Med Health R I; 2004 Apr 01; 87(4):98-100. PubMed ID: 15168633 [Abstract] [Full Text] [Related]
39. [Choice of antithrombotic therapy in atrial fibrillation, a daily challenge. No convincing evidence that warfarin is better than acetylsalicylic acid]. Mooe T. Lakartidningen; 2003 Aug 21; 100(34):2597-9, 2602-4. PubMed ID: 12968319 [Abstract] [Full Text] [Related]
40. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction. Fosbol EL, Wang TY, Li S, Piccini JP, Lopes RD, Shah B, Mills RM, Klaskala W, Alexander KP, Thomas L, Roe MT, Peterson ED. Am Heart J; 2012 Apr 21; 163(4):720-8. PubMed ID: 22520540 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]